ROHRIG HEIDEMARIE
No ORCID on file
· 17 papers in corpus
· active 1998
Frequent coauthors
- BERTRAM GUDRUN 17
- KURISCHKO ANATOLI 17
- KASCH HELMUT 17
- MENZENBACH BERND 17
- PONSOLD KURT 17
- SCHUBERT GERD 17
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …